NOV 08, 2016
Cornea/External Disease, Refractive Mgmt/Intervention
In this interview from AAO 2016, Dr. J. Bradley Randleman discusses the excitement over the long-awaited approval of corneal crosslinking in the United States. Though an established procedure internationally, Dr. Randleman urges ophthalmologist to proceed with caution and take the time to learn how to perform the procedure correctly and safely. Dr. Randleman is an original investigator in the U.S. clinical trials which began in 2008. He addresses the variety of protocols available today and offers his advice for implementing corneal crosslinking in your practice.